| DIRECT COMPETITOR COMPARISON | |
| RELV | HLF | MTEX | NATR | Industry | | Market Cap: | 39.02M | 2.31B | 76.00M | 138.19M | 164.79M | | Employees: | 247 | 4,000 | 540 | 1,183 | 86 | | Qtrly Rev Growth (yoy): | -12.50% | -0.30% | -8.60% | -7.40% | 20.50% | | Revenue (ttm): | 86.83M | 2.21B | 296.12M | 341.31M | 46.74M | | Gross Margin (ttm): | 80.62% | 46.62% | 33.73% | 79.68% | 56.06% | | EBITDA (ttm): | 5.06M | 338.70M | -13.62M | 9.75M | -6.49M | | Oper Margins (ttm): | 4.41% | 12.65% | -8.80% | 1.54% | 2.25% | | Net Income (ttm): | 2.00M | 181.35M | -18.90M | 1.62M | N/A | | EPS (ttm): | 0.149 | 2.862 | -0.714 | 0.105 | -0.17 | | P/E (ttm): | 21.41 | 13.23 | N/A | 84.86 | 17.97 | | PEG (5 yr expected): | 0.91 | 0.88 | N/A | N/A | 0.99 | | P/S (ttm): | 0.44 | 1.05 | 0.25 | 0.41 | 4.41 |
|
| HLF = Herbalife Ltd. | | MTEX = Mannatech Inc. | | NATR = Nature's Sunshine Products Inc. | | Industry = Drug Manufacturers - Other | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.21 | -0.44% | 56.92B | 12.69 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 54.09 | 2.37% | 15.64B | 18.10 | | Genzyme Corp. | GENZ | 54.87 | 0.70% | 14.56B | 31.28 | | Merck Serono S.A. | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.30 | 0.46% | 41.66B | 16.41 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 47.82 | 0.84% | 8.54B | 59.92 | | Teva Pharmaceutical Industries Limited | TEVA | 57.10 | 0.32% | 50.31B | 52.24 | | Sandoz International GmbH | Private - View Profile |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Watson Pharmaceuticals Inc. | WPI | 38.10 | 1.09% | 4.04B | 19.64 | | King Pharmaceuticals Inc. | KG | 11.44 | 1.24% | 2.84B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.68 | -0.45% | 5.40B | 108.47 | | Pfizer Inc. | PFE | 17.88 | 0.22% | 144.28B | 14.85 | | Johnson & Johnson | JNJ | 62.76 | 0.63% | 173.16B | 14.27 | | GlaxoSmithKline plc | GSK | 38.47 | 0.92% | 97.52B | 12.87 | | Sanofi-Aventis | SNY | 36.29 | 1.06% | 94.76B | N/A | | Novartis AG | NVS | 53.58 | 0.94% | 121.69B | 16.04 | | RHHBY.PK | 41.50 | 1.39% | N/A | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | AstraZeneca plc | AZN | 44.11 | 2.27% | 64.00B | 8.50 | | Abbott Laboratories | ABT | 53.35 | 0.00% | 82.52B | 14.44 | | Bristol-Myers Squibb Company | BMY | 24.25 | 1.21% | 48.04B | 4.53 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | NATR | | Nature's Sunshine Products Announces Court Approves Class Action Suit Settlement
Tue 4:32pm -
Business Wire | | • | MTEX | | Team Mannatech Athlete and Basketball Hall of Famer Nancy Lieberman Selected to Play in NBA All-Star Celebrity Game Feb. 12
Thu, Feb 4 -
Business Wire | | • | HLF | | Lightning Round OT: Nu Skin Enterprises, Tupperware Brands and More
Wed, Feb 3 -
at CNBC | | • | HLF | | Herbalife's Tips to Eat Right, Sleep Tight
Thu, Jan 28 -
Business Wire | | • | HLF | | Herbalife Ltd. Earnings Call scheduled for Wed, Feb 24
Wed, Jan 20 -
CCBN | | • | HLF | | Herbalife Ltd. Announces Fourth Quarter and Full Year 2009 Earnings Release Date and Investor Call
Wed, Jan 20 -
Business Wire | | • | HLF | | FDA Official Joins Herbalife
Tue, Jan 19 -
Business Wire | | • | MTEX | | Top Mannatech Winners Lose 30 Total Inches in Fat-Loss Challenge
Tue, Jan 19 -
Business Wire | | • | MTEX | | Mannatech Patents for Ambrotose® Product Validated in Case Against Techmedica and Ionx
Wed, Jan 13 -
Business Wire | | • | MTEX | | StemCells, Hutchison Telecom: Midday Volume Plays
Fri, Jan 8 -
at TheStreet.com | | • | MTEX | | Randomized, Double-Blind, Controlled Human Study Finds Mannatech's Ambrotose® Complex Improves Cognition and Well-Being*
Fri, Jan 8 -
Business Wire | | • | NATR | | NATURES SUNSHINE PRODUCTS INC Financials
Fri, Nov 13 -
EDGAR Online Financials | | • | NATR | | NATURES SUNSHINE PRODUCTS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
Thu, Nov 12 -
EDGAR Online | | • | NATR | | NATURES SUNSHINE PRODUCTS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Mon, Nov 9 -
EDGAR Online | | • | NATR | | NATURES SUNSHINE PRODUCTS INC Files SEC form 10-Q, Quarterly Report
Mon, Nov 9 -
EDGAR Online | | | All Headlines for these symbols... |
|
|
|
1.52% Nasdaq 
Competitors
